[HTML][HTML] Autophagy adaptor protein p62/SQSTM1 and autophagy-related gene Atg5 mediate autophagosome formation in response to Mycobacterium tuberculosis …

S Seto, K Tsujimura, T Horii, Y Koide - PloS one, 2013 - journals.plos.org
S Seto, K Tsujimura, T Horii, Y Koide
PloS one, 2013journals.plos.org
Mycobacterium tuberculosis is an intracellular pathogen that can survive within phagocytic
cells by inhibiting phagolysosome biogenesis. However, host cells can control the
intracellular M. tuberculosis burden by the induction of autophagy. The mechanism of
autophagosome formation to M. tuberculosis has been well studied in macrophages, but
remains unclear in dendritic cells. We therefore characterized autophagosome formation in
response to M. tuberculosis infection in dendritic cells. Autophagy marker protein LC3 …
Mycobacterium tuberculosis is an intracellular pathogen that can survive within phagocytic cells by inhibiting phagolysosome biogenesis. However, host cells can control the intracellular M. tuberculosis burden by the induction of autophagy. The mechanism of autophagosome formation to M. tuberculosis has been well studied in macrophages, but remains unclear in dendritic cells. We therefore characterized autophagosome formation in response to M. tuberculosis infection in dendritic cells. Autophagy marker protein LC3, autophagy adaptor protein p62/SQSTM1 (p62) and ubiquitin co-localized to M. tuberculosis in dendritic cells. Mycobacterial autophagosomes fused with lysosomes during infection, and major histcompatibility complex class II molecules (MHC II) also localized to mycobacterial autophagosomes. The proteins p62 and Atg5 function in the initiation and progression of autophagosome formation to M. tuberculosis, respectively; p62 mediates ubiquitination of M. tuberculosis and Atg5 is involved in the trafficking of degradative vesicles and MHC II to mycobacterial autophagosomes. These results imply that the autophagosome formation to M. tuberculosis in dendritic cells promotes the antigen presentation of mycobacterial peptides to CD4+ T lymphocytes via MHC II.
PLOS